2013 Tar Heel 10 Miler
Apr 20, 2013
from 08:00 AM to 12:00 PM
|Contact Name||Jennifer Bowman|
|Add event to calendar||
Chapel Hill, NC – For a third year, the Tar Heel 10 miler will benefit UNC Lineberger Comprehensive Cancer Center. Runners can register online at http://tarheel10miler.com and enter the code BEATCANCER5 to donate $5 per entry to cancer research and treatment in our community.
A $30 donation to the cancer center will be made for each volunteer who affiliates with UNC Lineberger. To volunteer, please contact Jennifer Bowman, UNC Lineberger's Special Event Coordinator.
“Thank you to Endurance Magazine for once again choosing UNC Lineberger as a charity partner,” said Shelley Earp, MD, UNC Lineberger’s director. “Our missions are aligned, we are all working to make Chapel Hill and North Carolina healthier.”
The races attracted more than 4,279 runners to Chapel Hill in April 2012. Among the crowds were UNC researchers, doctors, nurses and other staff – all running a hilly course to benefit cancer research and treatment at UNC Lineberger Comprehensive Cancer Center. Overall, more than $13,788 was raised for the cancer center’s programs. In 2013, race planners anticipate a full field of 5,000 runners.
Runners wishing to raise money for UNC Lineberger can create their own Tar Heel 10 Miler fundraising page here.
About Endurance Magazine
Endurance Magazine is the premier resource for active lifestyles in the Carolinas. Focused on educating, inspiring, and motivating athletes of all levels and abilities, Endurance Magazine offers compelling and immediately useful editorial and produces life-changing endurance events including distance running and triathlon events. For more information go to www.endurancemag.com.
About UNC Lineberger Comprehensive Cancer Center
As one of only 40 National Cancer Institute-designated comprehensive cancer centers, UNC Lineberger has brought together some of the most exceptional physicians and scientists in the country to combat cancer. The Center’s efforts span the spectrum from the laboratory to global practice, meaning that we work to understand the causes of cancer at the genetic and population levels, conduct groundbreaking laboratory research, and pioneer innovative clinical trials that bring the latest discoveries to patient bedsides. For more information, visit unclineberger.org.